BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7815569)

  • 1. Genetic factors in calcium oxalate stone disease.
    Goodman HO; Holmes RP; Assimos DG
    J Urol; 1995 Feb; 153(2):301-7. PubMed ID: 7815569
    [No Abstract]   [Full Text] [Related]  

  • 2. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multiple calcium oxalate stone formation in a patient with glycogen storage disease type I (von Gierke's disease) and renal tubular acidosis type I: a case report].
    Kanematsu A; Segawa T; Kakehi Y; Takeuchi H
    Hinyokika Kiyo; 1993 Jul; 39(7):645-8. PubMed ID: 8362684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leave no "stone" unturned: understanding the genetic bases of calcium-containing urinary stones in children.
    Thomas SE; Stapleton FB
    Adv Pediatr; 2000; 47():199-221. PubMed ID: 10959444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium oxalate stones in feline littermates.
    Byrne KM; Bynum K; Robinette L; Brownlee L
    J Feline Med Surg; 2000 Jun; 2(2):111-4. PubMed ID: 11716603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of high and low calcium diets on stone forming risk during liberal oxalate intake.
    Matsumoto ED; Heller HJ; Adams-Huet B; Brinkley LJ; Pak CY; Pearle MS
    J Urol; 2006 Jul; 176(1):132-6. PubMed ID: 16753387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of cellular oxalate in oxalate clearance of patients with calcium oxalate monohydrate stone formation and normal controls.
    Oehlschläger S; Fuessel S; Meye A; Herrmann J; Froehner M; Albrecht S; Wirth MP
    Urology; 2009 Mar; 73(3):480-3. PubMed ID: 19167040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone formers than in healthy controls: measurements with the [(13)C2]oxalate absorption test.
    Voss S; Hesse A; Zimmermann DJ; Sauerbruch T; von Unruh GE
    J Urol; 2006 May; 175(5):1711-5. PubMed ID: 16600737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of osteopontin as matrix protein in calcium-containing urinary stones.
    Yamate T; Umekawa T; Iguchi M; Kurita T; Kohri K
    Hinyokika Kiyo; 1997 Sep; 43(9):623-7. PubMed ID: 9365840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Indicators of the risk of calcium oxalate urinary calculi: comparative study of the Parks' and Tiselius' indices, urinary citrate/calciuria ratio, and morning crystalluria].
    Robert M; Boularan AM; Guiter J; Monnier L
    Prog Urol; 1996 Apr; 6(2):264-8. PubMed ID: 8777421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of E-cadherin gene 3'-UTR C/T polymorphism with calcium oxalate stone disease.
    Tsai FJ; Wu HC; Chen HY; Lu HF; Hsu CD; Chen WC
    Urol Int; 2003; 70(4):278-81. PubMed ID: 12740491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
    Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
    J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic urinary stone disease: possible polygenic aetiological factors.
    Watts RW
    QJM; 2005 Apr; 98(4):241-6. PubMed ID: 15781479
    [No Abstract]   [Full Text] [Related]  

  • 14. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genes in idiopathic calcium oxalate stone disease.
    Goodman HO; Brommage R; Assimos DG; Holmes RP
    World J Urol; 1997; 15(3):186-94. PubMed ID: 9228726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation.
    Stoller ML; Chi T; Eisner BH; Shami G; Gentle DL
    J Urol; 2009 Mar; 181(3):1140-4. PubMed ID: 19152919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arginine form of p21 gene codon 31 is less prominent in patients with calcium oxalate stone.
    Chen WC; Lu HF; Chen HY; Hsu CD; Tsai FJ
    Urol Res; 2001 Apr; 29(2):94-7. PubMed ID: 11396735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteocalcin gene Hind III polymorphism is not correlated with calcium oxalate stone disease.
    Chen WC; Chen HY; Wu JY; Chen YT; Tsai FJ
    Urol Res; 2001 Apr; 29(2):98-101. PubMed ID: 11396736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic disorders and urolithiasis.
    Danpure CJ
    Urol Clin North Am; 2000 May; 27(2):287-99, viii. PubMed ID: 10778471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset of stone diseases and primary hyperoxaluria.
    Topaloğlu R; Bakkaloğlu A; Saatçi U; Beşbaş N
    Int Urol Nephrol; 1990; 22(3):223-6. PubMed ID: 2210975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.